SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950157-22-001076
Filing Date
2022-09-30
Accepted
2022-09-30 16:06:52
Documents
12
Period of Report
2022-09-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8-k.htm   iXBRL 8-K 44923
  Complete submission text file 0000950157-22-001076.txt   183219

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gbt-20220930.xsd EX-101.SCH 3905
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20220930_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20220930_pre.xml EX-101.PRE 16031
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4083
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37539 | Film No.: 221284098
SIC: 2834 Pharmaceutical Preparations